Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
08/28/2012 | US8252570 Bone delivery device |
08/28/2012 | US8252557 Peptide-containing culture medium for culturing animal cell |
08/28/2012 | US8252556 Reverse cumate repressor mutant |
08/28/2012 | US8252537 5' portion of an intestinal lactase-phlorizine hydrolase (LPH) gene; point mutations; solid phase synthesis; immunoassay; vectors; primers; host cells; antibodies; kits; gene therapy |
08/28/2012 | US8252535 RNA interference tags |
08/28/2012 | US8252279 Nutrient broth comprising no cell attachment factors for use in propagation of neuronal cell lines |
08/28/2012 | CA2563675C Recombinantly modified plasmin |
08/28/2012 | CA2508925C Product quality enhancement in mammalian cell culture processes for protein production |
08/28/2012 | CA2479414C Inhibition of the .beta.3 subunit of l-type ca2+ channels |
08/28/2012 | CA2472161C Genetic sequences having methyltransferase activity and uses therefor |
08/28/2012 | CA2467383C Rapidly maturing fluorescent proteins and methods for using the same |
08/28/2012 | CA2463693C Sensitivity controls for blood serology prepared from modified cells |
08/28/2012 | CA2454073C Mutations in ion channels |
08/28/2012 | CA2450470C Method for rapid screening of bacterial transformants and novel simian adenovirus proteins |
08/28/2012 | CA2447851C Dual-specific ligand and its use |
08/28/2012 | CA2447391C Substantially homogeneous bio-affecting material having a pre-determined ratio of transferrin to doxorubicin, its method of manufacture and its method of use |
08/28/2012 | CA2398590C Cells for drug discovery |
08/28/2012 | CA2395632C A bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
08/28/2012 | CA2387805C Nucleic acids encoding endotheliases, endotheliases and uses thereof |
08/28/2012 | CA2337331C Transferring materials into cells using porous silicon |
08/28/2012 | CA2284110C An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method |
08/23/2012 | WO2012112982A2 Hydrogel encapsulated cells and anti-inflammatory drugs |
08/23/2012 | WO2012112958A2 High-throughput assays to probe leukemia within the stromal niche |
08/23/2012 | WO2012112933A1 Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate |
08/23/2012 | WO2012112776A2 Robust and efficient differentiation of human pluripotent stem cells to multipotent vascular progenitors |
08/23/2012 | WO2012112737A2 Alzheimer's disease cellular model for diagnostic and therapeutic development |
08/23/2012 | WO2012112620A1 Methods and compositions of producing patient-specific multipotent neuronal stem cells |
08/23/2012 | WO2012112603A1 Constructs and methods for generating induced pluri potent stem ( ips) cells |
08/23/2012 | WO2012112586A1 Genetically modified pigs for xenotransplantation of vascularized xenografts and derivatives thereof |
08/23/2012 | WO2012112576A1 Treatment of amyotrophic lateral sclerosis using umbilical derived cells |
08/23/2012 | WO2012112564A2 Human disc tissue |
08/23/2012 | WO2012112524A2 Media, kits, systems and methods for the micropropagation of monocotyledonous plants |
08/23/2012 | WO2012112458A2 Compositions and methods for increasing reprogramming efficiency |
08/23/2012 | WO2012112160A1 Compositions and methods of use for determination of he4a |
08/23/2012 | WO2012112013A2 A marker comprising anti-ck8/18 complex autoantibody and its use for diagnosing cancer |
08/23/2012 | WO2012111772A1 Polypeptide, isolated nucleic acid, recombinant vector, gene transfer kit, transformant, and method for regulating intracellular calcium signaling |
08/23/2012 | WO2012110856A1 Gmnac2 transcriptional gene and use thereof for enhancing plant tolerance to salt and/or drought |
08/23/2012 | WO2012110853A1 Gm wrky transcriptional gene and use thereof for enhancing plant tolerance to salt and/or drought |
08/23/2012 | WO2012110641A1 Cell culture method and system for establishing an in vitro model of the intestinal barrier |
08/23/2012 | WO2012110232A1 Method for producing a product using cells of the hair root sheath, product and kit |
08/23/2012 | WO2012092458A3 Compositions comprising placental stem cells and platelet rich plasma, and methods of use thereof |
08/23/2012 | WO2012091465A3 Monoclonal antibodies to serum amyloid a, and hybridoma cells producing same |
08/23/2012 | WO2012091165A9 Method for utilizing monoterpene glycosyltransferase |
08/23/2012 | WO2012088157A3 Glp-1 receptor agonists for islet cell transplantation |
08/23/2012 | WO2012078270A3 Efficient and effective supplement screening for the development of chemically defined media in cell culture |
08/23/2012 | WO2012074265A3 Composition for promoting the stability of stem cells |
08/23/2012 | WO2012064195A3 Genetically modified cell and process for use of said cell |
08/23/2012 | WO2012064090A9 Chemical preparation method of skeletal muscle-derived multipotent cells and use thereof |
08/23/2012 | US20120216321 Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom |
08/23/2012 | US20120216320 Method for modulating plant growth, nucleic acid molecules and polypeptides encoded thereof useful as modulating agent |
08/23/2012 | US20120216317 Nucleotide sequences and polypeptides encoded thereby useful for increasing plant size and increasing the number and size of leaves |
08/23/2012 | US20120216316 Amylopectin Type Starch with Enhanced Retrogradation Stability |
08/23/2012 | US20120216313 Spinach line sp6504 |
08/23/2012 | US20120216308 Tomato With Improved Shelf-Life |
08/23/2012 | US20120216306 Pea cultivar fp2291 |
08/23/2012 | US20120216305 Pea cultivar fp2311 |
08/23/2012 | US20120215018 Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
08/23/2012 | US20120214975 Aad-1 event das-40278-9, related transgenic corn lines, and event-specific identification thereof |
08/23/2012 | US20120214867 Bacteriophage T4 Nanoparticles for Eukaryotic Delivery |
08/23/2012 | US20120214863 Anti-miR-1 Therapy for Wound Healing |
08/23/2012 | US20120214744 Polypeptides and nucleic acids for treating erbb2-dependent cancers |
08/23/2012 | US20120214737 Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by nrg-2 |
08/23/2012 | US20120214728 Ex vivo and in vivo methods and related compositions for regenerating hematopoietic stem cell populations |
08/23/2012 | US20120214677 Luciferase biosensor |
08/23/2012 | US20120214243 Method of efficiently establishing induced pluripotent stem cells |
08/23/2012 | US20120214241 Zinc finger nuclease modification of leucine rich repeat kinase 2 (lrrk2) mutant fibroblasts and ipscs |
08/23/2012 | US20120214240 Vectors for generating pluripotent stem cells and methods of producing pluripotent stem cells using the same |
08/23/2012 | US20120214239 Plant biochemical systems and uses thereof |
08/23/2012 | US20120214238 Microbubble devices, methods and systems |
08/23/2012 | US20120214237 Compositions and methods useful for culturing differentiable cells |
08/23/2012 | US20120214236 Generating induced pluripotent stem cells and progenitor cells from fibroblasts |
08/23/2012 | US20120214235 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory |
08/23/2012 | US20120214234 iPS CELLS AND METHOD FOR PREPARING THE SAME |
08/23/2012 | US20120214233 Cystatin c as an antagonist of tgf-beta and methods related thereto |
08/23/2012 | US20120214232 Methods of culturing cells in a medium comprising transforming growth factor beta 1 and basic fibroblast growth factor |
08/23/2012 | US20120214231 Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays |
08/23/2012 | US20120214230 Cell culture/handling product and method for production and use thereof |
08/23/2012 | US20120214229 Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays |
08/23/2012 | US20120214217 In situ tissue engineering using magnetically guided three dimensional cell patterning |
08/23/2012 | US20120214208 Fusion polypeptides and uses thereof |
08/23/2012 | US20120214206 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS |
08/23/2012 | US20120214204 Cell culture media for uvc exposure and methods related thereto |
08/23/2012 | US20120214197 Polypeptides Having Glucoamylase Activity and Polynucleotides Encoding Same |
08/23/2012 | US20120214190 System and method based on blood components for estimating human physiological parameters |
08/23/2012 | US20120214188 Light-activated ion channel molecules and uses thereof |
08/23/2012 | US20120214178 Mesenchymal Stem Cells Expressing TNF-alpha Receptors |
08/23/2012 | US20120214163 Disease-associated genetic variations and methods for obtaining and using same |
08/23/2012 | US20120213809 Vault complexes for cytokine delivery |
08/23/2012 | US20120213808 Carbonic anhydrase i serving as novel antigen to be used for treatment of autoimmune diseases |
08/23/2012 | US20120213799 Compositions and methods for treating inflammatory disorders |
08/23/2012 | US20120213794 Ax213 and ax132 psck9 antagonists and variants |
08/23/2012 | US20120213788 Use of inhibitors of leukotriene b4 receptor blt2 for treating human cancers |
08/23/2012 | US20120213787 Stable anti-tnfr1 polypeptides, antibody variable domains & antagonists |
08/23/2012 | US20120213783 Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer |
08/23/2012 | US20120213782 Bmp10 antibodies and related methods |
08/23/2012 | US20120213781 Monovalent and Multivalent Multispecific Complexes and Uses Thereof |
08/23/2012 | US20120213780 Efficient mucosal vaccination mediated by the neonatal Fc receptor |
08/23/2012 | US20120213778 Method of detecting and treating tuberous sclerosis complex associated disorders |
08/23/2012 | US20120213777 Vascular endothelial growth factor 2 |
08/23/2012 | US20120213774 Antibodies against human IL33R and uses thereof |